Gastric cancer: new genetic developments
- PMID: 15895459
- DOI: 10.1002/jso.20214
Gastric cancer: new genetic developments
Abstract
Gastric cancer's (GC) incidence shows large geographic differences worldwide with the lowest rates occurring in most Western industrialized countries including the United States and the United Kingdom; in contrast, relatively high rates of GC occur in Japan, Korea, China, and South America, particularly Chile. The Laurén classification system classifies GC under two major histopathological variants: 1) an intestinal type and 2) a diffuse type. The intestinal type is more common in the general population, more likely to be sporadic and related to environmental factors such as diet, particularly salted fish and meat as well as smoked foods, cigarette smoking, and alcohol use. It exhibits components of glandular, solid, or intestinal architecture, as well as tubular structures. On the other hand, the diffuse type is more likely to have a primary genetic etiology, a subset of which, known as hereditary diffuse gastric cancer (HDGC), is due to the E-cadherin (CDH1) germline mutation. The diffuse type pathology is characterized by poorly cohesive clusters of cells which infiltrate the gastric wall, leading to its widespread thickening and rigidity of the gastric wall, known as linitis plastica. Helicobacter pylori infection is associated with risk for both the intestinal and diffuse varieties of gastric cancer. Germline truncating mutations of the CDH1 gene, which codes for the E-cadherin protein, were initially identified in three Maori families from New Zealand that were predisposed to diffuse GC. Since then, similar mutations have been described in more than 40 additional HDGC families of diverse ethnic backgrounds. It is noteworthy that two-thirds of HDGC families reported to date have proved negative for the CDH1 germline mutation. A number of candidate genes have been identified through analysis of the molecular biology of E-cadherin. Patients with evidence of the CDH1 germline mutation in the context of a family history of HDGC must be considered as candidates for prophylactic gastrectomy, given the extreme difficulty in its early diagnosis and its exceedingly poor prognosis when there is regional or distant spread. Specifically, the E-cadherin cytoplasmic tail interacts with catenins, assembling the cell-adhesion complex involved with E-cadherin mediated cell:cell adhesion. Beta-catenin and gamma-catenin compete for the same binding site on the E-cadherin cytoplasmic tail, directly linking the adhesion complex to the cytoskeleton through alpha-catenin. Beta-catenin gene (CTNNB1) mutations have been described predominantly in intestinal-type gastric cancers and CTNNB1 gene amplification and overexpression have recently been described in a mixed-type gastric cancer. This paper reviews the genetics of both intestinal and diffuse types of gastric carcinoma, their differential diagnosis, molecular genetics, pathology, and, when known, their mode of genetic transmission within families.
Copyright 2005 Wiley-Liss, Inc
Similar articles
-
Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.Am J Surg Pathol. 2008 Jun;32(6):799-809. doi: 10.1097/PAS.0b013e31815e7f1a. Am J Surg Pathol. 2008. PMID: 18391748
-
[From gene to disease; E-cadherin and hereditary diffuse gastric cancer].Ned Tijdschr Geneeskd. 2003 Dec 13;147(50):2474-7. Ned Tijdschr Geneeskd. 2003. PMID: 14708213 Review. Dutch.
-
Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred.Hum Mutat. 2002 May;19(5):510-7. doi: 10.1002/humu.10068. Hum Mutat. 2002. PMID: 11968083
-
CDH1 associated gastric cancer: a report of a family and review of the literature.Eur J Surg Oncol. 2005 Apr;31(3):259-64. doi: 10.1016/j.ejso.2004.12.010. Eur J Surg Oncol. 2005. PMID: 15780560 Review.
-
New aspects of Helicobacter pylori infection involvement in gastric oncogenesis.J Surg Res. 2008 May 1;146(1):149-58. doi: 10.1016/j.jss.2007.06.011. Epub 2007 Jul 27. J Surg Res. 2008. PMID: 17720195 Review.
Cited by
-
Disordered beta-catenin expression and E-cadherin/CDH1 promoter methylation in gastric carcinoma.World J Gastroenterol. 2006 Jul 14;12(26):4228-31. doi: 10.3748/wjg.v12.i26.4228. World J Gastroenterol. 2006. PMID: 16830381 Free PMC article.
-
Characteristics and prognosis of gastric cancer in young patients.Oncol Rep. 2013 Jul;30(1):43-9. doi: 10.3892/or.2013.2467. Epub 2013 May 15. Oncol Rep. 2013. PMID: 23674196 Free PMC article.
-
Polymorphisms in metabolic genes, their combination and interaction with tobacco smoke and alcohol consumption and risk of gastric cancer: a case-control study in an Italian population.BMC Cancer. 2007 Nov 8;7:206. doi: 10.1186/1471-2407-7-206. BMC Cancer. 2007. PMID: 17996038 Free PMC article.
-
Clinicopathological and prognostic significance of CD24 overexpression in patients with gastric cancer: a meta-analysis.PLoS One. 2014 Dec 12;9(12):e114746. doi: 10.1371/journal.pone.0114746. eCollection 2014. PLoS One. 2014. PMID: 25503963 Free PMC article.
-
An investigation of the factors effecting high-risk individuals' decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC).Fam Cancer. 2016 Oct;15(4):665-76. doi: 10.1007/s10689-016-9910-8. Fam Cancer. 2016. PMID: 27256430 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous